Insulet Corporation
PODDNASDAQHealthcare● Active
$153.22
+$6.81(+4.65%)
Market Cap$10.6B
P/E Ratio—
52W High$354.88
52W Low$140.63
Insulet Corporation (PODD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PODD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$1.42
Est. $1.19 · +19.3%
Revenue
$0.76B
Est. $0.73B · +4.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 7-Quarter EPS Beat Streak
PODD reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $1.45 | — | — | — | $0.79B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $1.19 | $1.42 | +19.3% | $0.76B | $0.73B | +4.4% |
| ▲ Q1 FY2026 | Feb 18, 2026 | $1.47 | $1.55 | +5.4% | $0.78B | $0.77B | +1.9% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $1.14 | $1.24 | +8.8% | $0.71B | $0.68B | +4.1% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.92 | $1.17 | +27.2% | $0.65B | $0.61B | +5.7% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.79 | $1.02 | +29.1% | $0.57B | $0.54B | +4.7% |
| ▲ Q1 FY2025 | Feb 20, 2025 | $1.00 | $1.15 | +15.0% | $0.60B | $0.58B | +2.6% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.76 | $0.90 | +18.4% | $0.37B | $0.52B | -28.3% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$1.45
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$1.42
EPS Est.
$1.19
EPS Surpr.
+19.3%
Revenue
$0.76B
Q1 FY2026
Feb 18, 2026Beat
EPS Actual
$1.55
EPS Est.
$1.47
EPS Surpr.
+5.4%
Revenue
$0.78B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$1.24
EPS Est.
$1.14
EPS Surpr.
+8.8%
Revenue
$0.71B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$1.17
EPS Est.
$0.92
EPS Surpr.
+27.2%
Revenue
$0.65B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$1.02
EPS Est.
$0.79
EPS Surpr.
+29.1%
Revenue
$0.57B
Q1 FY2025
Feb 20, 2025Beat
EPS Actual
$1.15
EPS Est.
$1.00
EPS Surpr.
+15.0%
Revenue
$0.60B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.90
EPS Est.
$0.76
EPS Surpr.
+18.4%
Revenue
$0.37B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $3.88 | $3.95 | $4.03 | 11 |
| Q3 FY2029 | $3.34 | $3.40 | $3.47 | 9 |
| Q2 FY2029 | $2.76 | $2.81 | $2.87 | 8 |
| Q1 FY2029 | $2.23 | $2.27 | $2.32 | 8 |
| Q4 FY2028 | $3.06 | $3.11 | $3.18 | 9 |
| Q3 FY2028 | $2.64 | $2.69 | $2.75 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $1.6B | $1.6B | $1.6B | 9 |
| Q3 FY2029 | $1.4B | $1.5B | $1.5B | 7 |
| Q2 FY2029 | $1.3B | $1.3B | $1.4B | 10 |
| Q1 FY2029 | $1.2B | $1.2B | $1.3B | 7 |
| Q4 FY2028 | $1.3B | $1.3B | $1.3B | 6 |
| Q3 FY2028 | $1.2B | $1.2B | $1.2B | 11 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +19.3% | $167.53 | $151.28 | -9.70% |
| ▲ Q1 FY2026 | Feb 18, 2026 | +5.4% | $246.34 | $258.07 | +4.76% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +8.8% | $314.44 | $323.40 | +2.85% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +27.2% | $277.30 | $303.55 | +9.47% |
| ▲ Q2 FY2025 | May 8, 2025 | +29.1% | $264.31 | $257.00 | -2.77% |
| ▲ Q1 FY2025 | Feb 20, 2025 | +15.0% | $283.68 | $288.29 | +1.63% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +18.4% | $239.30 | $244.98 | +2.37% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -2.5% | $190.39 | $199.79 | +4.94% |
Q2 FY2026-9.70%
Report Date
May 6, 2026
EPS Beat/Miss
+19.3%
Price Before
$167.53
Price After
$151.28
Q1 FY2026+4.76%
Report Date
Feb 18, 2026
EPS Beat/Miss
+5.4%
Price Before
$246.34
Price After
$258.07
Q4 FY2025+2.85%
Report Date
Nov 6, 2025
EPS Beat/Miss
+8.8%
Price Before
$314.44
Price After
$323.40
Q3 FY2025+9.47%
Report Date
Aug 7, 2025
EPS Beat/Miss
+27.2%
Price Before
$277.30
Price After
$303.55
Q2 FY2025-2.77%
Report Date
May 8, 2025
EPS Beat/Miss
+29.1%
Price Before
$264.31
Price After
$257.00
Q1 FY2025+1.63%
Report Date
Feb 20, 2025
EPS Beat/Miss
+15.0%
Price Before
$283.68
Price After
$288.29
Q4 FY2024+2.37%
Report Date
Nov 7, 2024
EPS Beat/Miss
+18.4%
Price Before
$239.30
Price After
$244.98
Q3 FY2024+4.94%
Report Date
Aug 8, 2024
EPS Beat/Miss
-2.5%
Price Before
$190.39
Price After
$199.79
Avg Beat Reaction+1.23%
Avg Miss Reaction+4.94%
Beat Rate7 / 8 quarters
Largest Move-9.70% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PODD ends December
Insulet Corporation (PODD) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $1.42 — beating the analyst consensus of $1.19 by +19.3%. PODD has beaten EPS estimates for 7 consecutive quarters. The next PODD earnings date is expected around September 1, 2026.
Each quarter, investors track PODD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PODD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PODD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PODD earnings · 5 questionsInsulet Corporation's next earnings report is expected around September 1, 2026. PODD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PODD historically reports after market close (AMC).
PODD earnings datewhen is PODD earningsPODD next earnings datewhen does PODD report earningsPODD earnings calendar
▸ Source: FMP · Insulet Corporation SEC filings · US GAAP · Insulet Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026